Connect with us

Published

on

Due to the imminent threat of climate change and expected legal measures, companies across different sectors are increasingly driven to set and actively pursue sustainability objectives.

The pharmaceutical sector, faced with rising stakeholder expectations and tightening regulations, is accelerating efforts to reduce its environmental impact. Several major players in the industry have committed to achieving net-zero emissions as their climate sustainability target. These leading pioneers are blazing the trail by implementing policies and undertaking initiatives, including the purchase of carbon credits, to accomplish this ambitious objective.

 

The pharmaceutical industry’s carbon footprint

The pharmaceutical sector is a significant contributor to global emissions. If it were a country, its carbon footprint would rank 9th in the world. Energy-intensive manufacturing processes, extensive distribution networks, and greenhouse gas-emitting propellants in inhalers drive up the industry’s climate impacts. Experts urge pharmaceutical companies to act, as unmitigated warming could strain global health systems and hinder access to vital medications.

While daunting, the mission is not impossible. Industries like tech and retail are demonstrating that reaching net-zero is within grasp. Google aims to run entirely on carbon-free energy by 2030. IKEA plans to become climate positive by 2030 by reducing more greenhouse gas emissions than its value chain emits. These commitments raise the bar for pharmaceutical companies to take equally bold climate action.

Major industry players are stepping up. AstraZeneca, Novartis, and Takeda have set ambitious net-zero targets, while investing in renewable energy, green chemistry innovation, and carbon removal. Their efforts are having ripple effects as peers follow suit. With collaboration and persistence, the pharmaceutical industry can curb its emissions in line with climate science.

 

AstraZeneca’s U$1BN of climate commitments

With over $26 billion in annual revenue, British-Swedish firm AstraZeneca is one of the world’s largest pharmaceutical companies. It manufactures blockbuster treatments ranging from diabetes to oncology medications.

In 2020, AstraZeneca announced its Ambition Zero Carbon strategy, aiming to achieve carbon neutrality across its entire value chain by 2030. This bold pledge puts AstraZeneca at the vanguard of climate action in pharma.

To meet its goal, AstraZeneca is transitioning to 100% renewable electricity at its sites by 2025. It is also optimizing manufacturing to curb emissions, while partnering with suppliers to reduce their carbon footprints. Further, AstraZeneca plans to eliminate fossil fuel vehicles from its fleet by 2030.

Beyond its operations, AstraZeneca is developing a portfolio of over $1 billion in green investments. These include carbon removal and storage solutions expected to offset about 2.5 million tonnes of CO2 annually by 2025.

AstraZeneca’s commitment is spurring the industry to accelerate sustainability initiatives. Being the pioneer in the pharmaceutical industry to establish a bold net-zero objective that encompasses its entire value chain, AstraZeneca is setting a remarkable example that its competitors will have to strive to emulate.

 

Novartis to use 100% renewable energy within 2023

Headquartered in Switzerland, Novartis is a leading global medicines company with over $48 billion in 2021 revenue. Its therapeutic areas span eye care, immunology, and cardiovascular treatments.

In 2021, Novartis announced its aim to achieve carbon neutrality across Scopes 1, 2, and 3 by 2040. Scope 1 and 2 cover direct emissions from Novartis’ operations, while Scope 3 includes indirect emissions across its supply chain.

Novartis’ environmental policies are publicly available on the internet. The company has made meeting its net-zero ambition a top priority, with a strong and focused approach in four crucial areas: sourcing renewable electricity, enhancing energy efficiency, promoting innovative green chemistry, and investing in carbon removal offsets.

Already, Novartis sources 80% of its electricity from renewables. It is also optimizing production processes, deploying automation, and modifying fleet vehicles to curb emissions. The company is on track to source 100% of its power from renewables by years’ end of 2023.

Additionally, Novartis is pioneering molecular design techniques to develop medicines with lower environmental impacts. Furthermore, the company is actively investing in projects that focus on nature-based carbon removal, such as collaborating with Carbon Direct to expand the implementation of carbon forestry offsets.

By setting and working toward net-zero science-based targets, Novartis is positioning itself as a leader in green pharmaceutical manufacturing. Its multipronged approach can serve as a model for other companies.

 

Takeda Pharmaceuticals shows the way for Asia

Japan’s largest pharmaceutical company, Takeda Pharmaceutical generates over $30 billion in annual revenue from medicines treating conditions from cancer to rare diseases.

In 2021, Takeda announced its commitment to achieving net-zero greenhouse gas emissions by 2040. It is working to reduce and offset its entire carbon footprint, including Scope 3 emissions from its supply chain.

Takeda is achieving its goal by increasing renewable electricity usage, improving energy efficiency at its sites, electrifying its vehicle fleet, and reducing emissions from business travel. It aims to cut Scopes 1 and 2 emissions 46% by 2030.

Takeda is also collaborating with pharmaceutical industry partners and suppliers to curb emissions across its value chain under the Pharmaceutical Supply Chain Initiative. And it plans to utilize carbon removal offsets for hard-to-abate emissions.

Takeda’s pledge to achieve net-zero marks a groundbreaking moment for the pharmaceutical industry in Asia and beyond, as they lead the charge towards comprehensive decarbonization. Its 2040 target and interim science-based milestones demonstrate meaningful leadership.

 

Pharma’s challenges in reaching net-zero

Despite strong commitments from sustainability front-runners, achieving net-zero emissions poses complex challenges for pharmaceutical companies. Many production processes inherently rely on fossil fuels as heat sources and for transporting materials. Companies need major capital investments to transition these operations to clean energy alternatives.

Pharmaceutical distribution and long, complex supply chains also make emissions reductions difficult. Cold chain storage and last-mile delivery result in substantial greenhouse gas outputs. Meanwhile, developing green chemistry solutions requires years of research and development, along with new manufacturing infrastructure. These costs can be prohibitive. Further, credibly offsetting all residual emissions will necessitate scaled up, verifiable carbon removal markets. Technical and economic hurdles remain for many offset types.

 

Overcoming Challenges

While obstacles exist, experts emphasize they can be solved through collaboration, innovation, and policy action.

Companies can join forces and share their knowledge and resources through initiatives like the Pharmaceutical Supply Chain Initiative. This collaboration enables them to not only expand their renewable energy procurement, but also boost their efficiency and make strides in green chemistry.

Governments can help by offering incentives for clean technology investments and funding research into pharmaceutical process improvements.

International cooperation can accelerate decarbonization of global supply chains. And standardized offset methodologies will ensure carbon removal credits have integrity.

Ultimately, reaching net-zero will depend on persistence, investment, and cross-industry partnership. But the health and environmental benefits make it imperative for pharmaceutical companies to see it through.

 

Opportunities from net-zero efforts

Pursuing net-zero also opens up opportunities for pharmaceutical companies to add business value, beyond environmental benefits. Optimizing processes for energy efficiency provides cost savings from reduced power consumption and heating needs. Streamlining supply chains also cuts costs over the long-term.

First movers on net-zero can boost their reputations with consumers and investors, who increasingly prioritize sustainability. These companies may have better talent recruitment and retention.

Developing and marketing lower carbon medicines can become a competitive advantage. Doctors and health systems are paying more attention to the climate footprint of drugs.

AstraZeneca’s partnerships have the potential to unlock opportunities for companies to venture into the burgeoning green investment markets. Through these collaborations, businesses can not only contribute to the sustainability of our planet but also reap financial benefits by investing in carbon removal and renewable energy projects.

Finally, building climate resilience helps ensure business continuity as physical impacts of climate change accelerate.

 

Government policy propels climate action

Governments are ramping up policies aimed at decarbonizing pharmaceutical value chains through incentives and requirements.

The Inflation Reduction Act of 2022 in the United States presents an extraordinary opportunity, providing over $60 billion in incentives dedicated to fostering energy efficiency, electrification, and groundbreaking advancements in green chemistry. This can offset costs for companies pursuing these strategies.

The EU’s pharmaceutical strategy aims to make drug manufacturing and distribution more sustainable by implementing green product design and procurement requirements. This will help reduce emissions.

India released a roadmap in 2022 pushing pharmaceutical companies to adopt renewable energy and assess Scope 3 climate impacts. It aims to help India meet its national climate targets.

Such policies encourage pharmaceutical companies to take ownership of their emissions and are likely to expand as more governments declare net-zero commitments.

 

The Road Ahead

While the 2030s and 2040s may seem like distant milestones, reaching net-zero requires immediate action across pharmaceutical supply chains. Industry leaders have provided a blueprint – including renewable energy procurement, distribution optimization, green chemistry, and carbon removal.

New technologies and nature-based solutions are expanding decarbonization opportunities. With collective willpower, strategic investment, and transparent reporting, net-zero is within the pharmaceutical industry’s reach. All stakeholders must maintain pressure and hold firms accountable to their pledges for a sustainable future.

 

Photo credit

Photo by Myriam Zilles on Unsplash

Carbon Footprint

U.S. Nuclear Industry Set for Big Changes as Government Plans to Cut Red Tape

Published

on

U.S. Nuclear Industry Set for Big Changes as Government Plans to Cut Red Tape

This is a special guest editorial from Katusa Research.

The U.S. nuclear power industry is about to experience its biggest shift in decades. The White House plans to announce new executive orders that could make the Nuclear Regulatory Commission (NRC) largely powerless. These orders let the Department of Energy (DoE) and Department of Defense (DoD) skip the NRC’s strict rules. This will speed up the construction of new nuclear power plants.

For over 5 decades, the NRC has been the main government agency overseeing nuclear plant safety and licensing. But many experts and industry leaders say the NRC’s complicated rules and slow approvals have stopped new nuclear plants from being built.

The NRC’s licensing process has grown from a simple 50-page document to an overwhelming 1,100 pages. The last approved reactor needed about 12,000 pages of paperwork. It also had millions of supporting documents.

Because of these heavy rules and outdated 1970s standards, the NRC hasn’t approved any new nuclear plant designs since 1978. Former NRC Commissioner Jeffrey Merrifield said the agency “doesn’t know when to stop” with new regulations. This is a major reason why new nuclear projects struggle to move forward.

US nuclear power electricity vs nuclear reactors
Source: Katusa Research

Why Both Political Parties Support Nuclear Energy

For the first time since President Nixon, both Democrats and Republicans agree on supporting nuclear power. Democrats want nuclear energy to help fight climate change and reach net-zero carbon goals. Republicans see it as vital for U.S. energy independence and creating new jobs.

Nuclear power is key to 3 big goals for the U.S.:

  • Nuclear Exports. The U.S. can regain leadership in exporting nuclear technology, which is expected to be a $1.9 trillion global market by 2050. Currently, China and Russia control two-thirds of this market.
  • National Security. Nuclear power supports the supply chain for nuclear weapons and is crucial for defense.
  • Energy Security. Nuclear energy offers a reliable, self-sufficient power source, helping reduce dependence on foreign energy.

Because of these reasons, Congress has passed multiple laws over the past decade to force the NRC to update and speed up its licensing process. But progress has been slow.

Other countries like Canada and the UK have already updated their nuclear approval systems. Canada is investing heavily in next-generation nuclear technology to amplify its clean power supply.

In 2024, the U.S. Congress passed the ADVANCE Act, which pushes the NRC to modernize. It aims to make reviews for advanced nuclear reactors simpler and faster. Still, the NRC has struggled to implement these changes.

Power Shift to the Department of Energy and Defense

The new executive orders will shift power away from the NRC and give more control to the Department of Energy and the Department of Defense. Both agencies strongly support nuclear energy and have large budgets to back new projects.

US federal nuclear energy budget
Source: Katusa Research

In 2022, the DoE started a $6 billion Civil Nuclear Credit Program. It aims to extend the life of current reactors and support new types of nuclear reactors. It’s also giving $1.5 billion to reopen the Palisades nuclear plant—the first such reopening in U.S. history. The DoE’s former secretary, Jennifer Granholm, said the U.S. needs to triple its nuclear reactors by 2050.

The DoD also uses nuclear power for its massive energy needs and owns mobile nuclear reactors. It can take risks that private companies cannot and has a budget that could fund enough nuclear power to cover 85% of U.S. electricity demand.

The DoD and DoE plan to team up and invest in advanced nuclear reactors. They aim to connect a new reactor to the grid in 3 years.

Why This Could Be a Historic Moment

These moves could kickstart a nuclear renaissance in the U.S., similar to the scale of the Manhattan Project during World War II. The government has signed contracts with companies to build advanced reactors by 2029. Billions of dollars in funding are expected to flow to this sector.

Experts believe this push will lower the cost of nuclear energy by about 60%, making it more competitive with other power sources. This could open new doors in uranium mining, nuclear fuel production, infrastructure, and nuclear tech investment.

What This Means for Private Nuclear Companies

The expected executive orders could be a game changer for private companies working on nuclear technology. Startups and energy developers have struggled for years. They deal with long delays, high costs, and complex paperwork to get approval for new nuclear reactors. Some applications have taken more than 10 years and cost hundreds of millions of dollars before a single shovel hits the ground.

With the NRC pushed aside, companies might finally have a faster path to approve and build new designs. This is key for startups creating advanced nuclear reactors and small modular reactors (SMRs). SMRs are smaller, safer, and easier to build than traditional plants.

Now, instead of waiting for NRC approval, companies may be able to work directly with the DoE or the DoD. These agencies are more supportive and flexible. They already have funding programs, partnerships with developers, and a goal to build advanced reactors quickly.

Private firms like TerraPower, X-energy, and Oklo have been waiting for years to move forward. Under the new system, these companies could see faster permits, more government contracts, and easier access to funding. They may even get a chance to work on national defense or grid reliability projects led by the DoE or DoD.

This shift could spark a wave of innovation, job creation, and clean energy development across the country. If it works, it could also encourage more investors to put money into nuclear startups—knowing the government is serious about getting projects built.

The Clock Is Ticking

With the new executive orders expected soon, the nuclear industry and investors have limited time to prepare for this wave of change. Many believe this could be one of the most important energy transitions in decades and offer profitable opportunities for those ready to act.

The post U.S. Nuclear Industry Set for Big Changes as Government Plans to Cut Red Tape appeared first on Carbon Credits.

Continue Reading

Carbon Footprint

Svante Opens World’s First Gigafactory for Carbon Capture in Canada

Published

on

Svante Opens World's First Gigafactory for Carbon Capture in Canada

Svante Technologies, a Canadian carbon capture company, has launched the world’s first commercial-scale gigafactory for carbon capture filters. This is a big step in the fight against climate change.

Located in Burnaby, British Columbia, the facility officially opened in May 2025. The factory will help speed up the use of carbon capture and storage (CCS) technologies by making the production of carbon filters faster and more cost-effective.

With rising global emissions and increased focus on net-zero goals, Svante’s new plant offers a timely solution. The gigafactory is built to capture millions of tons of carbon dioxide (CO₂) every year. It helps industries cut their carbon footprint and meet regulations. As the carbon capture market continues to grow, the facility could help change how industries respond to climate change.

Scaling Up: Inside the Burnaby Gigafactory

The 140,000-square-foot facility, named the Redwood City Gigafactory, is the first of its kind. Svante makes solid sorbent filters. These filters trap CO₂ from factories and even from the air. These filters are then integrated into carbon capture systems used in sectors such as cement, steel, hydrogen, and power generation.

Svante’s filter technology relies on a material called metal-organic frameworks (MOFs). These materials are known for their high surface area and ability to trap gas molecules like CO₂.

Compared to traditional systems, Svante’s filters are lighter, more compact, and faster to produce. They need less energy to regenerate. This leads to lower costs and fewer emissions during operation.

The facility can produce filter modules to capture up to 10 million tonnes of CO₂ each year, according to company estimates. That’s roughly the equivalent of taking over 2 million gasoline-powered cars off the road each year.

The Redwood factory is designed for rapid manufacturing and can scale up production as demand grows. The factory uses automation and digital tools. It also monitors data to boost quality control and cut waste.

Partnerships and Financial Support Fuel Growth

The construction and launch of the gigafactory would not have been possible without strong public and private backing. Svante raised $318 million in total since 2007, including a major $145 million Series E fundraising round in 2022.

Investors include: Chevron New Energies, United Airlines Ventures, Samsung Engineering & Construction, Temasek, GE Vernova, and Breakthrough Energy Ventures.

In addition to private investment, the Government of Canada contributed CA$25 million through its Strategic Innovation Fund. This funding sped up factory construction. It also shows Canada’s commitment to leading in carbon management technologies.

Beyond financing, Svante is also working with several partners to expand its reach. Here are some of their major partnerships:

  • Samsung E&A signed a joint development agreement to build skid-mounted modular carbon capture plants.

  • Climeworks, a direct air capture company, is using Svante filters for its next-generation CO₂ removal systems.

  • Tenaska, a U.S. energy firm, is working with Svante to develop end-to-end CCS projects that include capture, transportation, and storage of CO₂.

  • BASF signed a commercial agreement to supply Svante with CALF-20, an advanced MOF sorbent used in its filter systems.

These partnerships lower project risk, simplify deployment, and encourage CCS technology use in various sectors.

Market Drivers and Industry Demand

Demand for carbon capture technology is growing rapidly. According to BloombergNEF, the global market for carbon capture and removal could reach $100 billion by 2030. This growth comes from stricter climate rules, net-zero goals, and rising investment in clean tech.

  • If all the planned carbon capture projects are built and running by 2030, they could remove around 279 million tons of CO₂ a year—still just 0.6% of the emissions the world produces today.

global carbon capture projection 2030

For many industries—especially heavy emitters like cement, steel, and oil refining—carbon capture is one of the few practical solutions to reduce emissions. These sectors usually have few choices for using renewable energy. They need solutions that fit into their current infrastructure.

The International Energy Agency (IEA) states that to stay on track for net-zero emissions by 2050, the world will need to capture over 1.2 billion tonnes of CO₂ per year by 2030. Today, only about 50 million tonnes are captured annually.

carbon capture capacity by 2030 IEA
Source: IEA Report

Facilities like Svante’s gigafactory are crucial to scaling up the supply chain and meeting this growing need.

In the United States, the Inflation Reduction Act has also increased interest in carbon capture. The law boosts the value of the 45Q tax credit to $85 per tonne of CO₂ captured and stored. This financial support has made projects more attractive to investors and energy companies.

Building a Carbon Capture Economy

The launch of Svante’s gigafactory is more than a milestone for the company—it signals a shift in how carbon capture solutions can be delivered. Svante focuses on mass production, modular systems, and global partnerships. This approach aims to make carbon capture cheaper, faster, and more scalable.

CEO Claude Letourneau remarked:

“We’re also proud to launch this transformative manufacturing facility in Canada, which allows us to bring the supply chain to our shores and bring carbon management solutions closer to the needs of emitting industries in North America.”

Also, Svante’s method helps create a carbon market. Here, captured emissions become tradable carbon credits. As carbon pricing rises, expected to exceed $50 per tonne in some markets by 2026, industries may invest more in carbon removal for the long term.

The Redwood facility’s success could lead to new ways to use carbon. Captured CO₂ might be turned into fuels, building materials, or other products. This circular economy model can help industries not only reduce their footprint but also find new revenue streams.

Laying the Foundation for a Cleaner Future

Svante Technologies’ new gigafactory marks a major development in the carbon capture industry. As countries race to meet climate goals, scalable solutions like Svante’s are becoming essential. The Burnaby plant will focus on innovation, teamwork, and quick production. It will be vital in cutting industrial emissions.

By combining advanced materials with modern manufacturing, Svante is helping to make carbon capture more practical and affordable. Its efforts contribute to a growing movement to reduce global emissions and move toward a cleaner, more sustainable economy.

The post Svante Opens World’s First Gigafactory for Carbon Capture in Canada appeared first on Carbon Credits.

Continue Reading

Carbon Footprint

How EV Adoption is Reshaping Global Oil Demand: IEA’s 2025 Outlook and 2030 Forecast

Published

on

EV

For decades, oil was the backbone of global transport. It powered nearly every vehicle, pushing oil demand ever higher. Infrastructure significantly grew around extraction, refining, and distribution. But with mounting concerns over emissions and climate change, the search for cleaner alternatives gained momentum. Electric vehicles (EVs) have emerged as a game changer in this shift.

IEA recently published its Global EV Outlook 2025, where it has predicted,

  • By 2030, EVs are set to replace more than 5 million barrels of oil per day (mb/d) globally, with China’s expanding EV fleet making up half of that impact.

Let’s deep dive into this report and understand how the rise of EVs is impacting global oil demand.

The Rise of EVs and Its Impact on Global Oil Demand

By the end of 2024, the global electric car fleet reached nearly 58 million, more than triple the number in 2021. These EVs now make up about 4% of the global passenger car fleet.

The trend is strongest in China, where roughly 1 in 10 cars is electric. In Europe, the ratio is 1 in 20, but growing fast.

The UK, the second-largest car market in Europe, saw EVs take nearly 30% of new car sales in 2024. This rise was driven by the new Vehicle Emissions Trading Scheme, which required 22% of new car registrations to be battery electric or hydrogen fuel cell models.

With flexible credit borrowing allowed, manufacturers achieved nearly 20% EV sales. Norway led with near-total electrification. 88% of new cars sold were fully electric, and another 3% were plug-in hybrids.

As a result, Norway’s oil demand from the road fell 12% from 2021 to 2024. Denmark also saw a big jump, with EVs reaching 56% of new car sales in 2024 and nearly 100,000 units sold.

Meanwhile, Denmark is also seeing strong progress. In the latest figures, the share of electric cars jumped by 10 percentage points, reaching 56%, with nearly 100,000 EVs sold.

EV sales
Source: IEA

Oil Demand Drops as EV Fleet Grows Rapidly

Surge in EVs on roads came heavy on the oil industry. IEA says that electric vehicles slashed oil demand by over 1.3 million barrels per day (mb/d) in 2024.

It was a steep 30% jump from 2023, and the present figures are nearly equal to all the oil Japan currently uses for transportation.

Passenger cars and small vans classified as light-duty vehicles (LDVs) drive most of this shift. Today, they account for 80% of the oil displaced by EVs. By 2030, their share will slightly drop to 77% as electric trucks and buses gain traction.

This is because of the rapidly evolving batteries and stronger charging infrastructure, these heavy-duty vehicles will likely displace nearly 1 mb/d of oil within the decade.

EVs Cut Costs and Boost Energy Security

IEA analysts highlighted that even if global oil prices fall to $40 per barrel, EVs remain cost-effective especially with home charging. This way drivers can continue saving money by switching to electric vehicles.

In China, fast public charging costs about twice as much as charging at home. Yet, EVs still offer better fuel savings than gas-powered cars. As more people choose EVs, countries reduce their oil use and become less vulnerable to price shocks. This shift not only saves money but also strengthens national energy security.

Strong Policies Keep EV Adoption on Track

Although trade tensions, slow economic growth, and oil price drops may hurt overall car sales, these issues affect the market size more than the EV share. In China, steady government support and affordable EV prices continue to drive sales forward.

Meanwhile, in Europe, even though EVs cost more than traditional cars, long-term policies and past crisis responses help keep the market moving.

Additionally, Norway planned to raise taxes on traditional internal combustion engine (ICE) cars and plug-in hybrids (PHEVs) from April. This was meant to boost EV sales and help the country reach its goal of 100% zero-emission car sales by the end of 2025.

The 2025 EV outlook shows strong momentum. Despite economic uncertainty, EVs continue to grow thanks to smart policies, lower battery costs, and better infrastructure. As countries push for cleaner transportation, EVs are helping the world move toward a more sustainable, low-carbon future.

With over 58 million electric cars already on the road by the end of 2024—and more to come—the transition is well underway. This shift not only transforms the oil market but also puts the world on a clearer, more energy-secure path forward.

Global Oil Demand: What the Forecasts Say

We found the latest oil demand forecast in the International Energy Forum’s monthly comparative analysis of the oil market report. It highlights the following:

OPEC

OPEC expects oil demand to grow by around 1.3 million barrels per day (mb/d) in both 2025 and 2026. Almost all this growth will come from non-OECD countries, where demand is expected to rise by 1.2 mb/d each year. In contrast, OECD countries will see only a small increase of 0.1 mb/d annually.

EIA

The US Energy Information Administration (EIA) recently increased its 2025 forecast by 0.1 mb/d compared to last month. It now expects demand to rise by 1.0 mb/d next year. However, this is 0.4 mb/d lower than the estimate made in January 2025. For 2026, the EIA sees demand rising more slowly, by 0.9 mb/d.

IEA

The IEA has a more cautious view. It expects global oil demand to grow by 0.7 mb/d in 2025, even though OECD demand may fall by about 120,000 barrels per day. For 2026, the IEA sees demand increasing by 0.8 mb/d. According to its latest data, average yearly demand growth between 2022 and 2024 was just 0.3 mb/d.

oil demand
Source: IEF

To simplify it, the gap between the highest and lowest global oil demand forecasts is 0.6 mb/d for 2025 and 0.5 mb/d for 2026. These differences highlight the uncertainty that still surrounds future oil demand.

Furthermore, as electric vehicles gain popularity, governments are starting to feel the financial impact. Fuel taxes, which have been a key source of public funding for roads and transport, are shrinking. In 2022 alone, the global shift to EVs resulted in an estimated $9 billion drop in fuel tax revenues.

The post How EV Adoption is Reshaping Global Oil Demand: IEA’s 2025 Outlook and 2030 Forecast appeared first on Carbon Credits.

Continue Reading

Trending

Copyright © 2022 BreakingClimateChange.com